FNCH

FINCH THERAPEUTCS GRP INC by Finch Therapeutics Group, Inc. (FNCH)

About FINCH THERAPEUTCS GRP INC by Finch Therapeutics Group, Inc. (FNCH)

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.

Details

Daily high

$13.70

Daily low

$12.70

Price at open

$13.33

52 Week High

$16.10

52 Week Low

$11.50

Market cap

21.9M

Dividend yield

0.00%

Volume

2,201

Avg. volume

1,584

P/E ratio

-1.55

FINCH THERAPEUTCS GRP INC by Finch Therapeutics Group, Inc. News